Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02964130
Other study ID # 2016-A01144-47
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date May 31, 2019

Study information

Verified date July 2019
Source Poitiers University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study is part of a global project that aims to better define and understand features of FBSS/POPS "post-operative persistent syndrome patients (shortened as "FBSS" in the following project). FBSS is the acronym for Failed Back Surgery Syndrome, which has been defined as a chronic condition resulting from spinal interventions. Despite anatomically successful spine surgery, a significant proportion of patients is experiencing chronic refractory back and leg pain. In a recent multicentre study conducted on more than 100 refractory FBSS patients, (ESTIMET Study), the mean delay between pain occurrence and FBSS diagnosis was 5 years. Therefore, FBSS pattern and potential responder stratification might guide us to eventually develop a decision tool for identifying FBSS patients. Easing and helping diagnosis of FBSS should improve referral yield to specialists and accelerate patient flow through the care pathway. Hence, FBSS patients, who usually present a long standing history of pain, would have access to "appropriate" therapies earlier. This could lead to better outcomes. The aim of this multicentre, prospective study is to collect specific data that are not collected in routine in order to better define and understand the potential FBSS population and to accelerate the diagnostic and optimize the choice of appropriate treatment.

A multidisciplinary approach through a pain management clinical network, as it has been structured in Poitiers, will ensure that an exhaustive characterization of FBSS patients and their care pathway will be collected. In addition, since the cooperation between orthopaedic and neuro spine surgeons is not a common relationship found all over Europe (as it is observed in Poitiers), this study also aims to better understand the development of interactions between physicians/professionals and the substantial advantage which would result from bridging this gap. The N3MT (NeuroMapping Tools) software developed in Poitiers to collect data and assess objectively pain surface and intensity changes, before/after any treatment, with quantitative measurements, will be used as the central key of this project.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date May 31, 2019
Est. primary completion date May 16, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patient has signed and dated the Informed Consent Form.

- Patient is = 18 years of age at time of "Informed Consent Form" signature.

- Patient had most recent back surgery more than 6 months ago.

- Patient has developed post-operative Chronic Back with or without Leg Pain (potential FBSS).

- Patient has persistent back pain for more than 6 months.

- Average low back or leg pain is = 4 as assessed by the baseline NPRS.

Exclusion Criteria:

- Patient has already a confirmed FBSS diagnosis.

- Patient is or has been treated with SCS, subcutaneous or peripheral nerve stimulation, an intrathecal drug delivery system.

- Investigator suspects substance abuse that might confound the study results.

- Patient has a life expectancy of less than 12 months beyond study enrollment.

- Patient is less than 18 years of age.

- Patient is pregnant or planning to become pregnant during the course of the study.

- Patient is unable to undergo study assessments or complete questionnaires independently (e.g., is illiterate).

- Patient is a member of a vulnerable population.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No name


Locations

Country Name City State
France Poitiers Hospital University Poitiers

Sponsors (1)

Lead Sponsor Collaborator
Poitiers University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of clinical diagnosis of FBSS Incidence of clinical diagnosis of FBSS in the broad population of post-surgical pain syndrome, identified by multidisciplinary team of independent experts (1 pain physician, 1 neurosurgeon and 1 psychiatric), with morphological and clinical characterization of the syndrome. 12 month-follow up visit
Secondary Pain intensity (NRPS) Reduction of the NRPS score measuring pain intensity: Global pain, Back pain and Leg pain.
Proportion of patients with NRPS score < 4.
Proportion of patients obtaining a reduction = 25%, 50% and 75%: Global pain, Back pain and Leg pain NRPS.
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Secondary Pain surface and intensity (Mapping Tool) Reduction of the Global Pain Surface measured on the NeuroPain't module of the software, during treatment, before/after a therapeutic strategy is used.
Reduction of pain intensities associated with the quantitative surface measurements.
Reduction of the mechanical/neuropathic component of objective pain.
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Secondary Functional capacity (ODI) Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Secondary Quality of life (EQ5D) Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Secondary Psychological State (HADS) Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Secondary Pain Catastrophizing Scale (PCS CF) Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Secondary Adverse Events/ Serious Adverse Events Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain